VIRUSMYTH HOMEPAGE


BOARD OF DIRECTORS


Board of Directors of the Group for the Scientific Reappraisal of the HIV-AIDS Hypothesis:

  • Etienne de Harven MD. Member and Professor in cell biology, Sloan Kettering Institute, New York, 1956-1981. Isolated and obtained the first electron microscopic studies of the murine Friend leukemia virus, and retroviral budding. Co-director of the Electron Microscopy Laboratory at the Banting Institute, Department of Pathology, University of Toronto. He is also a member of South Africa's Presidential AIDS Advisory Panel.

  • David Crowe HBSc Hons. Biology/Mathematics, 1978 (Lakehead University, Ontario). President, Alberta Reappraising AIDS Society. Treasurer, Green Party of Alberta.

  • Peter H. Duesberg PhD. Professor of molecular and cell biology at the University of California, Berkeley. In 1968-1970 he demonstrated that influenza virus has a segmented genome. This would explain its unique ability to form recombinants by reassortment of subgenomic segments. He isolated the first cancer gene through his work on retroviruses in 1970, and mapped the genetic structure of these viruses. This, and his subsequent work in the same field, resulted in his election to the National Academy of Sciences in 1986. He was also the recipient of a seven-year Outstanding Investigator Grant from the National Institutes of Health from 1985-1992. He is also a member of South Africa's Presidential AIDS Advisory Panel.

  • Charles Geshekter PhD. Professor of African history at California State University, Chico, recipient of grants from the Ford Foundation, Fulbright-Hayes, National Endowment for the Humanities and Social Science Research Council. From 1991-95, he chaired the History of Science Section of the AAAS and was a member of its Executive Council. He is also a member of South Africa's Presidential AIDS Advisory Panel.

  • Roberto A. Giraldo MD. (University of Antioquia, Colombia, specialty internal medicine); Master of Science in infectious and tropical diseases (U. of London, The London School of Hygiene and Tropical Medicine). Member of South Africa's Presidential AIDS Advisory Panel.

  • Claus Koehnlein MD. Specialist in internal medicine, Dept. of Oncology, Univ. of Kiel, Germany (1983 -1993). Since 1993, in private practice increasingly treating HIV- positive people who decline antiviral drugs. Member of SA Presidential AIDS Advisory Panel.

  • Robert Leppo BA. Stanford University (1965); MBA, Harvard Business School (1969). Historian, philanthropist, and investor.

  • David Rasnick PhD. Senior Researcher, Rath Health Foundation, Africa. Between 1978 and 1996, he worked as a pharmaceutical protein chemist at Abbott Laboratories, Enzyme Systems Products, Prototek, Inc., and Khepri Pharmaceuticals. He was a visiting scholar at the department of molecular and cell biology, UC Berkeley (1996-2005), where he worked in the Duesberg laboratory on the aneuploidy theory of cancer. He is also a member of South Africa's Presidential AIDS Advisory Panel.

  • Gordon Stewart M.D. Emeritus Professor of Public Health, Univ Glasgow, UK; Formerly professor of epidemiology, Univ. NC at Chapel Hill, NC; Watkins Chair of Epidemiologyepid and professor medicine, Tulane Univ., New Orleans, LAa; consultant, New York City Health Dept; WHO; Senior Visiting Fellow, US National Science Foundation; emeritus fellow, Infectious Diseases Soc. America. Member of South Africa's Presidential AIDS Advisory Panel.


See also The Group's official website.


VIRUSMYTH HOMEPAGE